University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Hospital


Location: Leuven, Belgium (BE) BE

ISNI: 0000000406263338

ROR: https://ror.org/0424bsv16

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Potential and Uncertainties of RejectClass in Acute Kidney Graft Dysfunction: An Independent Validation Study. (2024) Von Samson-Himmelstjerna FA, Kakavand N, Gleske C, Schraml F, Basta AA, Braunisch MC, Bräsen JH, et al. Journal article Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE Study (2024) Häge A, Man KK, Inglis SK, Buitelaar J, Carucci S, Danckaerts M, Dittmann RW, et al. Journal article Comparison of diagnostic spectrum between inflammation of unknown origin and fever of unknown origin: A systematic review and meta-analysis (2024) Betrains A, Moreel L, Mulders-Manders CM, Auwaerter PG, Torné-Cachot J, Weitzer F, Terasawa T, et al. Journal article Update on olfactory neuroblastoma (2024) Lopez F, Agaimy A, Franchi A, Suárez C, Vander Poorten V, Mäkitie AA, Homma A, et al. Journal article, Review article Endovascular therapy of isolated posterior cerebral artery occlusion stroke with and without general anesthesia (2024) Berberich A, Herweh C, Qureshi MM, Strambo D, Michel P, Räty S, Abdalkader M, et al. Journal article The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants (2024) Furia F, Levy AM, Theunis M, Bamshad MJ, Bartos MN, Bijlsma EK, Brancati F, et al. Journal article Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial (2024) Mann JF, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, et al. Journal article Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial (2023) Koch R, Haveman L, Ladenstein R, Brichard B, Jürgens H, Cyprova S, van den Berg H, et al. Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia (2023) Khoshiwal AM, Frei NF, Pouw RE, Goldblum J, Montgomery E, Davison J, Singh J, et al. Journal article